Revenue, last quarter
$151.9K
−78.7% vs same quarter last year
Net income
−$1.4M
−30.1% vs same quarter last year
EPS, diluted
−$0.98
+94.2% vs same quarter last year
Operating cash flow
−$689.6K
−258.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.9M | −$10.5M |
| FY24 | $9.3M | −$12.5M |
| FY23 | $9.9M | −$11.1M |
| FY22 | $10.4M | −$10.2M |
| FY21 | $11.1M | −$9M |
| FY20 | $8.2M | −$4.7M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 11.2% | −465.4% | −543.7% |
| FY24 | 45% | −137% | −134.5% |
| FY23 | 51.9% | −112.5% | −111.8% |
| FY22 | 54.3% | −97.9% | −98.5% |
| FY21 | 52.9% | −53.2% | −80.5% |
| FY20 | 56.2% | −29.4% | −56.8% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$4.2M |
| FY24 | −$8.3M |
| FY23 | −$5.8M |
| FY22 | −$6M |
| FY21 | −$10.7M |
| FY20 | −$288.8K |
| FY19 | - |
- iSpecimen
- Healthcare median
Show the numbers
| Year | iSpecimen | Healthcare median |
|---|---|---|
| FY25 | −543.7% | −40.6% |
| FY24 | −134.5% | −60.7% |
| FY23 | −111.8% | −97.1% |
| FY22 | −98.5% | −128.5% |
| FY21 | −80.5% | −129.2% |
| FY20 | −56.8% | −136.5% |
| FY19 | - | −133.7% |
News
No stories filed under iSpecimen yet - coverage appears here as the news feed clusters it.